Liquid Biopsy

biopsia-liquida

Liquid biopsy group is focused on studying the tumour material in biological fluids, mainly blood from breast and prostate cancer patients. There are different tumour materials that can be analysed: circulating tumour cells (CTCs) which cause metastasis, tumoural genetic material ctDNA/ctRNA, extracellular vesicles and other blood components such as platelets.

Our main goal is isolated and molecular characterized both CTCs and tumoral genetic material in the circulatory system to identify prognostic biomarkers of response, resistance and possible therapeutic targets.

Ongoing projects:

- Liquid biopsy for precision oncology.

- Identification of resistance mechanisms to systemic treatment in Luminal advanced breast cancer.

- New approaches in Liquid Biopsy: study of blood biomarkers with diagnostic utility in breast cancer and its function in the metastatic cascade.


Team

CLOTI
Clotilde Costa Nogueira
Head of the Liquid Biopsy Line of the Roche-Chus Joint Unit
CARMEN
Carmen Abuín Redondo
Laboratory Technician of the Roche-Chus Joint Unit
FOTO 1
Miriam González Conde
Predoctoral student of the Roche-Chus
dig
Celso Yañez Gómez
Predoctoral student of the Roche-Chus
logo-oncomet-def_1
0
Roche_70

La Unidad Mixta Roche-Chus está cofinanciada por la Axencia Galega de Innovación, GAIN de la Xunta de Galicia: “Subvención a organismos de investigación de Galicia para a creación, posta en marcha e impulso de Unidades Mixtas de Investigación” de la Xunta de Galicia en el marco del Plan Galego de Investigación, Innovación e Crecemento- i2C.

logo-gain
c_ceei